Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms

Seminars in Cancer Biology
Dona SinhaAnupam Bishayee

Abstract

Globally, breast cancer is the most frequently diagnosed cancer among women. The major unresolved problems with metastatic breast cancer is recurrence after receiving objective response to chemotherapy, drug-induced side effects of first line chemotherapy and delayed response to second line of treatment. Unfortunately, very few options are available as third line treatment. It is clear that under such circumstances there is an urgent need for new and effective drugs. Phytochemicals are among the most promising chemopreventive treatment options for the management of cancer. Resveratrol (3,5,4'-trihydroxy-trans-stilbene), a non-flavonoid polyphenol present in several dietary sources, including grapes, berries, soy beans, pomegranate and peanuts, has been shown to possess a wide range of health benefits through its effect on a plethora of molecular targets.The present review encompasses the role of resveratrol and its natural/synthetic analogue in the light of their efficacy against tumor cell proliferation, metastasis, epigenetic alterations and for induction of apoptosis as well as sensitization toward chemotherapeutic drugs in various in vitro and in vivo models of breast cancer. The roles of resveratrol as a phytoestrogen, an ...Continue Reading

References

Mar 15, 1996·Clinica Chimica Acta; International Journal of Clinical Chemistry·C R Pace-AsciakD M Goldberg
May 22, 1998·Breast Cancer Research and Treatment·P HohenbergerP M Schlag
Apr 25, 2000·Journal of Agricultural and Food Chemistry·T H SandersK W Hendrix
Oct 31, 2000·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C De SantiG M Pacifici
Feb 13, 2001·Microscopy Research and Technique·J RussoI H Russo
Feb 28, 2002·Biochemical and Biophysical Research Communications·Kathleen BoveMin-Fu Tsan
Mar 23, 2002·Bioorganic & Medicinal Chemistry Letters·Li-Ming YangTsang-Hsiung Yang
May 16, 2002·Journal of Agricultural and Food Chemistry·Jennifer BurnsAlan Crozier
Jan 30, 2003·Clinical Biochemistry·David M GoldbergGeorge J Soleas
May 2, 2003·The Journal of Pharmacy and Pharmacology·Mark I KaldasThomas Walle
Sep 18, 2003·Journal of Agricultural and Food Chemistry·Mary M LyonsRichard B van Breemen
Oct 18, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Francesca ScarlattiRiccardo Ghidoni
Nov 19, 2003·The Journal of Steroid Biochemistry and Molecular Biology·E R Simpson
Jan 30, 2004·International Journal of Cancer. Journal International Du Cancer·Eulalia Pozo-GuisadoPedro M Fernández-Salguero
Apr 15, 2004·Seminars in Reproductive Medicine·Evan R Simpson
Aug 25, 2004·Planta medica·A Douglas KinghornJohn M Pezzuto
Aug 31, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Thomas WalleU Kristina Walle
Feb 3, 2005·International Journal of Cancer. Journal International Du Cancer·Eulalia Pozo-GuisadoPedro M Fernandez Salguero
Feb 3, 2005·International Journal of Cancer. Journal International Du Cancer·Mauro ProvincialiArianna Smorlesi
Mar 22, 2005·Molecular Nutrition & Food Research·Elisabeth Wenzel, Veronika Somoza
Mar 24, 2005·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·F LeviC La Vecchia
Mar 24, 2005·Molecular Nutrition & Food Research·Ludovic Le CorreD J Bernard-Gallon
Apr 2, 2005·Neoplasia : an International Journal for Oncology Research·Nicolas G Azios, Suranganie F Dharmawardhane
Jul 23, 2005·Endocrinology·Sharda VyasDaisy D De León
Sep 27, 2005·The Journal of Dairy Research·Artemissia-Phoebe NifliElias Castanas
Oct 28, 2005·Journal of Medicinal Chemistry·Filippo MinutoloRiccardo Ghidoni
Jan 20, 2006·The New England Journal of Medicine·James D Yager, Nancy E Davidson
Apr 14, 2006·Toxicological Sciences : an Official Journal of the Society of Toxicology·Yun WangLai K Leung
May 30, 2006·Nature Reviews. Drug Discovery·Joseph A Baur, David A Sinclair
Jul 11, 2006·BioFactors·Ki Won Lee, Hyong Joo Lee
Aug 25, 2006·Molecular Cancer Therapeutics·Heng-Yuan TangHung-Yun Lin

❮ Previous
Next ❯

Citations

Jan 25, 2014·Cancer Cell International·Carly C BarronEvangelia Tsiani
May 1, 2016·Alcoholism, Clinical and Experimental Research·Kevin D ShieldJürgen Rehm
May 13, 2015·Prostaglandins, Leukotrienes, and Essential Fatty Acids·M BessadóttirH M Ögmundsdóttir
Jun 25, 2016·International Journal of Molecular Sciences·Ming HongYibin Feng
Aug 28, 2016·Seminars in Cancer Biology·Anupam Bishayee, Gautam Sethi
Sep 15, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Gurinder Singh, Roopa S Pai
Jul 31, 2013·International Immunopharmacology·Nilesh M KalariyaKota V Ramana
Jun 4, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Chengzhi ChenZunZhen Zhang
Nov 26, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hélène LossonMarc Diederich
Nov 30, 2016·Scientific Reports·Lin-Lin DengJiong Wu
Mar 16, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jing-Ru WengChia-Hsien Feng
Mar 8, 2017·ChemMedChem·Barbara De FilippisRosa Amoroso
Jul 5, 2017·Annals of the New York Academy of Sciences·Lucia BiasuttoMario Zoratti
Dec 2, 2017·International Journal of Molecular Sciences·Jeong-Hyeon KoKwang Seok Ahn
Oct 27, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Wenrui WangChangjie Chen
Mar 3, 2018·International Journal of Molecular Sciences·Ammad Ahmad FarooqiAamir Ahmad
Jan 29, 2019·Molecular Nutrition & Food Research·María Ángeles Ávila-GálvezJuan Carlos Espín
Mar 25, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Yang SunShi-Bing Su
Dec 24, 2018·Canadian Journal of Physiology and Pharmacology·Xavier Lieben LouisJeffrey T Wigle
Apr 28, 2019·Cells·Natalia A Riobo-Del GaldoEva V Wertheimer
Aug 24, 2019·Molecular Nutrition & Food Research·Juan Antonio Giménez-BastidaAntonio González-Sarrías
Jul 18, 2020·Journal of Leukocyte Biology·Li-Juan DengJia-Xu Chen
Apr 24, 2018·Evidence-based Complementary and Alternative Medicine : ECAM·Sarmistha Mitra, Raju Dash
Mar 22, 2020·International Journal of Molecular Sciences·Abdullah ShaitoGianfranco Pintus
Jun 27, 2020·Cancers·Flávia Alves VerzaMozart Marins
Aug 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Danielly C Ferraz da CostaEliane Fialho
Aug 23, 2019·Critical Reviews in Toxicology·Tian YangYing-Yong Zhao
Jul 7, 2019·International Journal of Molecular Sciences·Jagoba IturriJosé Luis Toca-Herrera
Apr 20, 2018·Phytotherapy Research : PTR·Bahare SalehiJavad Sharifi-Rad
Sep 13, 2018·Biomedicines·Bahare SalehiJavad Sharifi-Rad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Phytochemistry Reviews : Proceedings of the Phytochemical Society of Europe
Nisha R ParikhAnupam Bishayee
Anti-cancer Drugs
Nicoletta GaglianoIsabella Dalle-Donne
Anti-cancer Agents in Medicinal Chemistry
Seyed Fazel NabaviSeyed Mohammad Nabavi
© 2022 Meta ULC. All rights reserved